Signalling

Our laboratory is primarily focused on elucidating the molecular mechanisms that enable cancer cells to develop resistance to multiple anticancer therapies. In particular, we investigate the TRIBBLES family of pseudokinases and their contribution to tumor initiation, progression, and therapeutic resistance.